TABLE 1.
Univariate analysis of indicators between non-hyperuricemia group and hyperuricemia group.
| Variables | Total (n = 200) | Non-HUA group (n = 111) | HUA group (n = 89) | Statistic | P |
|---|---|---|---|---|---|
| Age (y), M (Q1, Q3) | 12.00 (11.00, 13.00) | 11.00 (10.00, 12.00) | 12.00 (11.00, 13.00) | Z = −3.77 | < 0.001 |
| Age, n (%) | χ2 = 12.32 | < 0.001 | |||
| ≤ 12 y | 138 (69.00) | 88 (79.28) | 50 (56.18) | ||
| > 12 y | 62 (31.00) | 23 (20.72) | 39 (43.82) | ||
| Gender, n (%) | χ2 = 2.03 | 0.154 | |||
| Male | 145 (72.50) | 76 (68.47) | 69 (77.53) | ||
| Female | 55 (27.50) | 35 (31.53) | 20 (22.47) | ||
| HAZ, Mean ± SD | 0.92 ± 1.09 | 0.86 ± 0.97 | 0.99 ± 1.22 | t = −0.81 | 0.419 |
| BMIZ, Mean ± SD | 2.72 ± 0.56 | 2.62 ± 0.55 | 2.84 ± 0.55 | t = −2.81 | 0.005 |
| BMIZ, n (%) | χ2 = 4.18 | 0.041 | |||
| ≤ 2.7 | 106 (53.00) | 66 (59.46) | 40 (44.94) | ||
| > 2.7 | 94 (47.00) | 45 (40.54) | 49 (55.06) | ||
| Body fat percentage, Mean ± SD | 0.39 ± 0.06 | 0.39 ± 0.07 | 0.38 ± 0.06 | t = 0.68 | 0.497 |
| Visceral fat area (cm2), M (Q1, Q3) | 117.10 (86.75, 144.95) | 119.35 (87.00, 154.30) | 115.40 (86.75, 132.55) | Z = −0.92 | 0.358 |
| Blood urate level (μmol/L), M (Q1, Q3) | 405.00 (349.00, 469.25) | 356.00 (321.50, 387.00) | 476.00 (445.00, 520.00) | Z = −12.02 | < 0.001 |
| 25 (OH)D level (ng/ml), M (Q1, Q3) | 22.15 (18.78, 25.90) | 22.20 (18.72, 26.40) | 22.00 (18.80, 25.62) | Z = −0.04 | 0.969 |
| Vitamin D deficiency, n (%) | χ2 = 0.08 | 0.784 | |||
| No | 126 (63.00) | 69 (62.16) | 57 (64.04) | ||
| Yes | 74 (37.00) | 42 (37.84) | 32 (35.96) | ||
| Total cholesterol (mmol/L), M (Q1, Q3) | 4.59 (4.06, 5.05) | 4.57 (3.96, 4.88) | 4.63 (4.16, 5.13) | Z = −1.28 | 0.199 |
| LDL cholesterol (mmol/L), M (Q1, Q3) | 2.62 (2.23, 3.07) | 2.54 (2.19, 2.89) | 2.71 (2.38, 3.23) | Z = −2.05 | 0.041 |
| HDL cholesterol (mmol/L), M (Q1, Q3) | 1.16 (1.05, 1.29) | 1.18 (1.09, 1.34) | 1.15 (1.02, 1.27) | Z = −1.59 | 0.113 |
| Triglyceride (mmol/L), M (Q1, Q3) | 1.24 (0.91, 1.71) | 1.15 (0.87, 1.54) | 1.31 (0.98, 1.81) | Z = −1.45 | 0.146 |
| Dyslipidemia, n (%) | χ2 = 9.01 | 0.003 | |||
| No | 122 (61.00) | 78(70.27) | 44 (49.44) | ||
| Yes | 78(39.00) | 33(29.73) | 45 (50.56) | ||
| Fasting insulin (pmol/L), M (Q1, Q3) | 183.50 (116.25, 272.25) | 155.50 (109.75, 231.32) | 215.00 (147.75, 299.25) | Z = −2.60 | 0.009 |
| Hyperinsulinemia, n (%) | χ2 = 11.99 | < 0.001 | |||
| No | 97 (48.50) | 66 (59.46) | 31 (34.83) | ||
| Yes | 103 (51.50) | 45 (40.54) | 58 (65.17) | ||
| HbA1c (%), M (Q1, Q3) | 5.80 (5.60, 6.10) | 5.80 (5.60, 6.10) | 5.70 (5.50, 5.93) | Z = −1.49 | 0.135 |
| FBG (mmol/L, M (Q1, Q3) | 5.00 (4.75, 5.22) | 5.01 (4.74, 5.23) | 4.99 (4.75, 5.19) | Z = −0.35 | 0.725 |
| ALT (U/L), M (Q1, Q3) | 25.00 (17.00, 41.00) | 23.00 (16.00, 31.00) | 31.00 (19.50, 55.00) | Z = −3.56 | < 0.001 |
| ALT level, n (%) | χ2 = 15.04 | < 0.001 | |||
| Normal | 150 (75.00) | 96 (86.49 | 56 (62.92) | ||
| Abnormal | 50 (25.00) | 15 (13.51) | 33 (37.08) | ||
t, t-test; Z, Mann-Whitney test; χ2, Chi-square test; SD, standard deviation; M, Median; Q1, 1st Quartile; Q3, 3rd Quartile. Bold values represent results with statistical significance (P < 0.05).